Paul F. Truex, President and CEO at Anthera Pharmaceuticals Inc (ANTH), sold 54,000 shares at $7.16 ($107K) on 2011-05-16, disclosed to the SEC on 2011-05-18.
Scheduled sale ($107k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 30,000 | $0 | 0.0% |
| 2 | $0.00 | 9,000 | $0 | 0.0% |
| 3 | $7.16 | 15,000 | $107K | 100.0% |
| Total | $1.99 avg | 54,000 | $107K | 100% |
| Filing → |
| ANTH | BUY | 2012-07-02 | $15K | — | Filing → |
| ANTH | SELL | 2012-02-17 | $118K | — | Filing → |
| ANTH | SELL | 2012-01-19 | $101K | — | Filing → |